However, because XLA is caused by a BTK null phenotype, any perturbations within the coding region of BTK (insertions/deletions at the editing site) will likely not result in novel deleterious effects, highlighting a key advantage to gene editing for complete loss-of-function disorders.53 The gene discussed is BTK; the disease is Bruton-type agammaglobulinemia.